French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
暂无分享,去创建一个
O. Rascol | F. Durif | D. Weintraub | J. Corvol | A. Elbaz | T. Vidal | A. Marques | P. Derkinderen | G. Mangone | F. Artaud | B. Pereira | F. Pineau | Eve Benchetrit | F. Cormier | Hana You | J. Socha | Monique Galitstky | Elsa Pomies | Julie Socha
[1] M. Vidailhet,et al. Longitudinal analysis of impulse control disorders in Parkinson disease , 2018, Neurology.
[2] D. Siskind,et al. Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[3] C. Mariani,et al. Long‐term cognitive follow‐up of Parkinson's disease patients with impulse control disorders , 2015, Movement disorders : official journal of the Movement Disorder Society.
[4] K. Dujardin,et al. International validation of a behavioral scale in Parkinson's disease without dementia , 2015, Movement disorders : official journal of the Movement Disorder Society.
[5] C. Baumann,et al. Impulse control disorders in Parkinson's disease: don't set your mind at rest by self‐assessments , 2015, European journal of neurology.
[6] G. Deuschl,et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease (QUIP) and the QUIP-rating scale in a German speaking sample , 2014, Journal of Neurology.
[7] P. Christos,et al. Prospective cohort study of impulse control disorders in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[8] Daniel Weintraub,et al. Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale , 2012, Movement disorders : official journal of the Movement Disorder Society.
[9] A. Lang,et al. Impulse control disorders in parkinson disease: A multicenter case–control study , 2011, Annals of neurology.
[10] P. Barone,et al. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[11] P. Barone,et al. Impulsivity and compulsivity in drug‐naïve patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[12] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[13] A. Lang,et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.
[14] Han-Joon Kim,et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. , 2010, Parkinsonism & related disorders.
[15] F. Durif,et al. Evaluation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease , 2014 .
[16] Daniel Weintraub,et al. Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[17] A. Siderowf,et al. Long‐term follow‐up of impulse control disorders in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[18] Dagmar Verbaan,et al. Assessment of psychiatric complications in Parkinson's disease: The SCOPA‐PC , 2007, Movement disorders : official journal of the Movement Disorder Society.
[19] V. Voon,et al. Medication-related impulse control and repetitive behaviors in Parkinson disease. , 2007, Archives of neurology.
[20] P. Moberg,et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.
[21] M. Potenza,et al. Impulse control disorders in adult psychiatric inpatients. , 2005, The American journal of psychiatry.
[22] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.
[23] The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.
[24] I Litvan,et al. The FAB: A frontal assessment battery at bedside , 2000, Neurology.
[25] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[26] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[27] P. Cras,et al. Impulse control disorders in Parkinson’s disease: an overview from neurobiology to treatment , 2014, Journal of Neurology.
[28] C. Terwee,et al. Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.
[29] M J Buxton,et al. Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.
[30] H. Mayberg,et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.